Protovir human anti-cytomegalovirus: Temporary halt in a Phase II trial

A company-sponsored trial in CMV infections in patients undergoing bone marrow transplant is ongoing. The Phase II trial has shown no increase in mortality or adverse events so far, with nearly all pa...